Valuation (53%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 17.37 | N/A |
| PEG Ratio (TTM) | -11.70 | N/A |
| P/S Ratio (TTM) | 2.82 | N/A |
| P/B Ratio (TTM) | 1.21 | N/A |
| P/FCF Ratio (TTM) | 89.03 | N/A |
| Price to 5YR AVG Earnings Ratio | 14.87 | N/A |
| Price to 5YR AVG FCF Ratio | 12.97 | N/A |
Profitability (40%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 0.87% | N/A |
| ROE (TTM) | 7.19% | N/A |
| Net Profit Margin (TTM) | 16.30% | N/A |
| ROIC 5YR AVG | 22.92% | N/A |
Growth (62%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 1.72% | 18.19% | 4.27% |
| Revenue | 3.26% | 8.66% | 5.10% |
| Net Income | 2.10% | 18.86% | 5.13% |
| Cash Flow | -74.36% | 366.01% | 203.39% |
Health (47%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 0.55 | N/A |
| Quick Ratio (TTM) | 0.55 | N/A |
| D/E Ratio (TTM) | 0.12 | N/A |
| Interest Coverage (TTM) | 0.58 | N/A |
| Piotroski F-Score | 7 | N/A |
| Altman Z-Score | 0.19 | N/A |
| LTL to 5YR AVG FCF | 1.30 | N/A |
| Shares Outstanding Growth 5YR AVG | 0.97% | N/A |